Eliem Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 24, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Company Description
- Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
- Market
- Neuronal excitability disorders
- Location
- Redmond, Washington, USA
- Coinvestors
- Access Biotechnology, Acorn Bioventures, Intermediate Capital Group, LifeArc, RA Capital Management, Samlyn Capital